Bicara Therapeutics Inc. Common Stock (BCAX) Stock Price
Bicara Therapeutics Inc. Common Stock (NASDAQ: BCAX) last traded at $23.90, down 2.01% on the session. The quote above updates while this page is open; the figures below are drawn from Bicara Therapeutics Inc. Common Stock’s own filings and are restated only when a new one is published.
Bicara Therapeutics Inc. Common Stock (BCAX) company overview
Bicara Therapeutics Inc. Common Stock trades on NASDAQ under the ticker BCAX. Its market capitalisation is $1.58 billion.
BCAX valuation
Valuation measures for Bicara Therapeutics Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
Market cap
$1.58B
Enterprise value
$1.53B
Price / book
3.37
Beta
1.02
BCAX financials
Trailing-twelve-month figures tagged in Bicara Therapeutics Inc. Common Stock's XBRL filings with the SEC.
Net income (TTM)
-$185.36M
EPS (TTM)
-$3.09
Return on equity
-39.54%
Cash
$96.60M
BCAX trading statistics
Range and volume for BCAX over the past 52 weeks.
52-week high
$30.99
52-week low
$10.30
Volume
487.3K
Average volume
724.6K
Previous close
$24.39
Bicara Therapeutics Inc. Common Stock (BCAX) FAQs
What is the BCAX stock price today?
Bicara Therapeutics Inc. Common Stock (BCAX) last traded at $23.90, down 2.01% on the session. FurlPay quotes BCAX from Yahoo Finance and stamps each figure with the exchange time it printed.
What exchange is BCAX listed on?
Bicara Therapeutics Inc. Common Stock is listed on NASDAQ under the ticker symbol BCAX.
What is Bicara Therapeutics Inc. Common Stock's market cap?
Bicara Therapeutics Inc. Common Stock has a market capitalisation of $1.58 billion, derived from its shares outstanding as reported in its SEC filings and the latest quoted price.
What is BCAX's 52-week range?
Over the past 52 weeks BCAX has traded between $10.29 and $30.99.
Data sources
Price, range and volume — Yahoo Finance. Quotes may be delayed; each carries the exchange timestamp it printed with.
Financials and valuation — the company’s own XBRL filings with the U.S. Securities and Exchange Commission (CIK 0002023658), period ending 2026-06-30.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.
BCAX Stock Price & Quote | Bicara Therapeutics Inc. Common Stock | FurlPay